Biniszkiewicz Detlev 4/A
4/A · iTeos Therapeutics, Inc. · Filed Oct 21, 2020
Insider Transaction Report
Form 4/AAmended
Biniszkiewicz Detlev
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-23+16,608→ 0 totalExercise: $19.00Exp: 2030-07-23→ Common Stock (16,608 underlying)
Footnotes (1)
- [F1]This amendment is being filed solely for the purpose of correcting the vesting schedule, as follows: this stock option shall vest on the earlier of (i) the first anniversary of the grant date or (ii) the Company's next annual meeting of stockholders following the grant date, subject to continued service through the applicable vesting date.